SYNOPSIS
Renal cell carcinoma (RCC) exhibits a diverse and heterogeneous disease spectrum, but insight into its behavior has provided an improved understanding of potential risk factors, natural history of disease, and imaging features. Appropriately performed, CT and MRI may allow for the identification and accurate preoperative subtyping of RCC and for the assessment of a response to various therapies. Active surveillance is receiving increasing attention as a viable management option in select subgroup of patients and has provided further insight into the natural history of RCC, including the favorable prognosis of cystic renal neoplasms. In this article, we provide a brief review of the epidemiologic, clinical, and imaging features of RCC and the potential role of screening in selected high-risk populations.